{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:03:26Z","timestamp":1790298206403,"version":"4.1.0"},"reference-count":38,"publisher":"Bioscientifica","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>\n                    Primary hyperparathyroidism (pHPT) is rarely caused by parathyroid carcinoma (PC, &lt;1\u20135% of pHPT cases). The TET proteins oxidize the epigenetic mark 5-methylcytosine to 5-hydroxymethylcytosine (5hmC) and inactivation by mutation or epigenetic deregulation of\n                    <jats:italic>TET1<\/jats:italic>\n                    and\n                    <jats:italic>TET2<\/jats:italic>\n                    play important roles in various cancers. Recently, we found that 5hmC was severely reduced in all of the analyzed PCs and with deranged expression of TET1 for the majority of PCs. Here, we have examined the expression of the TET2 protein in 15 5hmC-negative PCs from patients who had local invasion or metastases. Cell growth and cell migratory roles for TET2 as well as epigenetic deregulated expression were addressed. Immunohistochemistry revealed very low\/undetectable expression of TET2 in all PCs and verified for two PCs that were available for western blotting analysis. Knockdown of TET2 in the parathyroid cell line sHPT-1 resulted in increased cell growth and increased cell migration. DNA sequencing of\n                    <jats:italic>TET2<\/jats:italic>\n                    in PCs revealed two common variants and no obvious inactivating mutations. Quantitative bisulfite pyrosequencing analysis of the\n                    <jats:italic>TET2<\/jats:italic>\n                    promoter CpG island revealed higher CpG methylation level in the PCs compared to that in normal tissues and treatment of a PC primary cell culture with the DNA methylation inhibitor 5-aza-2\u2032-deoxycytidine caused increased expression of the methylated\n                    <jats:italic>TET2<\/jats:italic>\n                    gene. Hence, the data suggest that deregulated expression of\n                    <jats:italic>TET2<\/jats:italic>\n                    by DNA hypermethylation may contribute to the aberrantly low level of 5hmC in PCs and further that TET2 plays a cell growth and cell migratory regulatory role and may constitute a parathyroid tumor suppressor gene.\n                  <\/jats:p>","DOI":"10.1530\/erc-17-0009","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T20:30:31Z","timestamp":1498163431000},"page":"329-338","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":20,"title":["A role for TET2 in parathyroid carcinoma"],"prefix":"10.1530","author":[{"given":"Elham","family":"Barazeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olov","family":"Norl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Fausto","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"St\u00e5lberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2017062217301807000_24.7.309.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-210039"},{"key":"2017062217301807000_24.7.309.2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248"},{"key":"2017062217301807000_24.7.309.3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13148-016-0197-2","article-title":"5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma","volume":"8","author":"Barazeghi","year":"2016","journal-title":"Clinical Epigenetics"},{"key":"2017062217301807000_24.7.309.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.11.056"},{"key":"2017062217301807000_24.7.309.5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbadis.2014.04.010","article-title":"TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells","volume":"1842","author":"Calabrese","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"key":"2017062217301807000_24.7.309.6","doi-asserted-by":"publisher","DOI":"10.1530\/EC-13-0046"},{"key":"2017062217301807000_24.7.309.7","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.080218"},{"key":"2017062217301807000_24.7.309.8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","article-title":"Primary hyperparathyroidism a current perspective","volume":"132","author":"DeLellis","year":"2008","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"2017062217301807000_24.7.309.9","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-013-9294-3"},{"key":"2017062217301807000_24.7.309.10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cellular Oncology"},{"key":"2017062217301807000_24.7.309.11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.316"},{"key":"2017062217301807000_24.7.309.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2014.07.005"},{"key":"2017062217301807000_24.7.309.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-005-0555-6"},{"key":"2017062217301807000_24.7.309.14","doi-asserted-by":"publisher","DOI":"10.1038\/nature09303"},{"key":"2017062217301807000_24.7.309.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205690"},{"key":"2017062217301807000_24.7.309.16","doi-asserted-by":"publisher","DOI":"10.1038\/nature09208"},{"key":"2017062217301807000_24.7.309.17","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200133"},{"key":"2017062217301807000_24.7.309.18","doi-asserted-by":"publisher","DOI":"10.1038\/nature09586"},{"key":"2017062217301807000_24.7.309.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2012.02213.x"},{"key":"2017062217301807000_24.7.309.20","doi-asserted-by":"publisher","DOI":"10.1038\/nature19057"},{"key":"2017062217301807000_24.7.309.21","doi-asserted-by":"crossref","first-page":"26591","DOI":"10.1038\/srep26591","article-title":"Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers","volume":"6","author":"Li","year":"2016","journal-title":"Scientific Reports"},{"key":"2017062217301807000_24.7.309.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.07.033"},{"key":"2017062217301807000_24.7.309.23","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.4081\/hr.2014.5333","article-title":"TET2 promoter DNA methylation and expression analysis in pediatric B-cell acute lymphoblastic leukemia","volume":"6","author":"Musialik","year":"2014","journal-title":"Hematology Reports"},{"key":"2017062217301807000_24.7.309.24","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/onc.2016.376","article-title":"TET2 binds the androgen receptor and loss is associated with prostate cancer","volume":"36","author":"Nickerson","year":"2016","journal-title":"Oncogene"},{"key":"2017062217301807000_24.7.309.25","doi-asserted-by":"crossref","first-page":"31322","DOI":"10.18632\/oncotarget.8900","article-title":"TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression","volume":"7","author":"Pei","year":"2016","journal-title":"Oncotarget"},{"key":"2017062217301807000_24.7.309.26","doi-asserted-by":"publisher","DOI":"10.1101\/gad.276568.115"},{"key":"2017062217301807000_24.7.309.27","doi-asserted-by":"publisher","DOI":"10.1101\/gad.260174.115"},{"key":"2017062217301807000_24.7.309.28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13073-015-0134-6","article-title":"TET proteins and the control of cytosine demethylation in cancer","volume":"7","author":"Scourzic","year":"2015","journal-title":"Genome Medicine"},{"key":"2017062217301807000_24.7.309.29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.beem.2010.01.003","article-title":"Clinical and molecular genetics of parathyroid neoplasms","volume":"24","author":"Sharretts","year":"2010","journal-title":"Best Practice and Research: Clinical Endocrinology and Metabolism"},{"key":"2017062217301807000_24.7.309.30","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-294"},{"key":"2017062217301807000_24.7.309.31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3136"},{"key":"2017062217301807000_24.7.309.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1170116"},{"key":"2017062217301807000_24.7.309.33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0493"},{"key":"2017062217301807000_24.7.309.34","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.326"},{"key":"2017062217301807000_24.7.309.35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/joim.12458","article-title":"Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours","volume":"280","author":"Westin","year":"2016","journal-title":"Journal of Internal Medicine"},{"key":"2017062217301807000_24.7.309.36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0739"},{"key":"2017062217301807000_24.7.309.37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3238"},{"key":"2017062217301807000_24.7.309.38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/wrr.12426","article-title":"AGE-induced keratinocyte MMP-9 expression is linked to TET2-mediated CpG demethylation","volume":"24","author":"Zhang","year":"2016","journal-title":"Wound Repair and Regeneration"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/24\/7\/329.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/ERC-17-0009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:54:08Z","timestamp":1784555648000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/24\/7\/329-338\/27041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1530\/erc-17-0009","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}